11 – 20 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
(
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
(
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
(
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
(
- Contribution to journal › Article
-
Mark
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Feasibility and Relevance of an Intervention with Systematic Screening as a Base for Individualized Rehabilitation in Breast Cancer Patients : A Pilot Trial of the ReScreen Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
(
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
(
- Contribution to journal › Article